방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| Sheehan Disability Scale (SDS)× | 우울 증상 신속 평가 척도 (QIDS)× | |
|---|---|---|
| 분야 | 임상심리학 | 임상심리학 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1983 | 2003 |
| 창시자≠ | David V. Sheehan | A. John Rush |
| 유형≠ | Self-report questionnaire | Self-report or clinician-administered questionnaire |
| 원전≠ | Sheehan, D. V. (1983). The Anxiety Disease. New York: Scribner. ISBN: 9780684183078 | Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Ninan, P. T. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583. DOI ↗ |
| 별칭≠ | SDS, Sheehan Disability Scale | QIDS, Quick Inventory of Depressive Symptomatology-Self Report, QIDS-SR |
| 관련 | 4 | 4 |
| 요약≠ | The Sheehan Disability Scale is a brief three-item self-report measure designed by David V. Sheehan to assess functional impairment across work/school, social life, and family life domains in psychiatric and medical disorders. First described in Sheehan's 1983 book 'The Anxiety Disease' and validated in multiple studies since, the SDS quantifies the degree to which a patient's illness interferes with major life domains. It is widely used in psychiatric research and clinical practice to assess the functional impact of depression, anxiety, ADHD, and other conditions, complementing symptom severity measures by capturing real-world impairment. | The Quick Inventory of Depressive Symptomatology is a 16-item assessment designed by A. John Rush and colleagues to efficiently measure the severity of depressive symptoms in adults. Published in Biological Psychiatry in 2003, the QIDS exists in both self-report (QIDS-SR) and clinician-rated (QIDS-C) versions. It was developed as a brief alternative to the longer Inventory of Depressive Symptomatology (IDS, 30 items) while maintaining comprehensive coverage of DSM-IV depressive symptoms. The QIDS has become a standard outcome measure in treatment research, particularly in large comparative effectiveness trials. |
| ScholarGate데이터셋 ↗ |
|
|